Deerfield Management Company as of March 31, 2018
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 116 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mallinckrodt Pub | 4.3 | $125M | 8.6M | 14.48 | |
| Mylan Nv | 3.6 | $105M | 2.5M | 41.17 | |
| Homology Medicines | 3.4 | $98M | 5.2M | 18.70 | |
| Horizon Pharma | 3.2 | $94M | 6.6M | 14.20 | |
| Avexis | 3.2 | $93M | 756k | 123.58 | |
| Horizon Pharma Plc convertible security | 3.2 | $91M | 99M | 0.92 | |
| Anaptysbio Inc Common (ANAB) | 2.9 | $83M | 794k | 104.08 | |
| CVS Caremark Corporation (CVS) | 2.4 | $70M | 1.1M | 62.21 | |
| Dbv Technologies S A (DBVT) | 2.3 | $67M | 2.9M | 23.07 | |
| Centene Corporation (CNC) | 2.2 | $63M | 588k | 106.87 | |
| Kempharm Inc note 5.500% 2/0 | 2.0 | $57M | 75M | 0.76 | |
| Myokardia | 1.8 | $52M | 1.1M | 48.80 | |
| Glaukos (GKOS) | 1.8 | $51M | 1.6M | 30.83 | |
| Dex (DXCM) | 1.7 | $48M | 649k | 74.16 | |
| Aclaris Therapeutics (ACRS) | 1.7 | $48M | 2.7M | 17.52 | |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 1.6 | $45M | 46M | 0.99 | |
| Lannett Company | 1.5 | $44M | 2.7M | 16.05 | |
| Anthem (ELV) | 1.4 | $42M | 191k | 219.70 | |
| Audentes Therapeutics | 1.4 | $42M | 1.4M | 30.05 | |
| Editas Medicine (EDIT) | 1.3 | $38M | 1.2M | 33.15 | |
| Trn 4% 04/01/45 | 1.3 | $38M | 48M | 0.80 | |
| Wright Medical Group Nv 2.25 20211115 | 1.2 | $36M | 32M | 1.14 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $35M | 7.4M | 4.77 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.2 | $35M | 41M | 0.86 | |
| Blueprint Medicines (BPMC) | 1.2 | $35M | 379k | 91.70 | |
| Portola Pharmaceuticals | 1.1 | $33M | 1.0M | 32.66 | |
| Intersect Ent | 1.1 | $33M | 833k | 39.30 | |
| DaVita (DVA) | 1.1 | $32M | 486k | 65.94 | |
| Select Medical Holdings Corporation (SEM) | 1.1 | $32M | 1.9M | 17.25 | |
| GlaxoSmithKline | 1.1 | $32M | 810k | 39.07 | |
| Ascendis Pharma A S (ASND) | 1.1 | $32M | 483k | 65.40 | |
| Universal Health Services (UHS) | 1.1 | $31M | 262k | 118.41 | |
| Nevro Corp note 1.750% 6/0 | 1.1 | $31M | 28M | 1.13 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $30M | 366k | 81.78 | |
| Natera (NTRA) | 1.0 | $30M | 3.2M | 9.27 | |
| Acadia Healthcare (ACHC) | 1.0 | $29M | 741k | 39.18 | |
| Intercept Pharmas conv | 1.0 | $28M | 36M | 0.79 | |
| Aetna | 1.0 | $28M | 165k | 169.00 | |
| Flamel Technologies Sa (AVDL) | 1.0 | $28M | 3.8M | 7.29 | |
| Arena Pharmaceuticals | 0.9 | $28M | 697k | 39.50 | |
| Xencor (XNCR) | 0.9 | $27M | 883k | 29.98 | |
| Aerie Pharmaceuticals | 0.9 | $26M | 484k | 54.25 | |
| Argenx Se (ARGX) | 0.9 | $26M | 320k | 80.44 | |
| Gw Pharmaceuticals Plc ads | 0.9 | $25M | 226k | 112.67 | |
| Dfb Healthcare Acquistion Co unit 01/30/2023 | 0.9 | $25M | 2.5M | 10.05 | |
| Endocyte | 0.8 | $24M | 2.6M | 9.09 | |
| Acceleron Pharma | 0.8 | $24M | 615k | 39.10 | |
| Walgreen Boots Alliance (WBA) | 0.8 | $23M | 356k | 65.47 | |
| K2m Group Hldgs Inc bond | 0.8 | $23M | 20M | 1.17 | |
| Melinta Therapeutics | 0.8 | $23M | 3.1M | 7.40 | |
| Aimmune Therapeutics | 0.8 | $23M | 710k | 31.83 | |
| Biohaven Pharmaceutical Holding | 0.8 | $22M | 869k | 25.76 | |
| Depomed Inc conv | 0.8 | $22M | 27M | 0.81 | |
| Aac Holdings | 0.7 | $21M | 1.9M | 11.48 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $21M | 753k | 28.45 | |
| Catalyst Biosciences | 0.7 | $21M | 831k | 25.80 | |
| Radius Health Inc note 3.000% 9/0 | 0.7 | $21M | 21M | 1.01 | |
| McKesson Corporation (MCK) | 0.7 | $21M | 150k | 140.87 | |
| Oxford Immunotec Global | 0.6 | $18M | 1.4M | 12.45 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $17M | 146k | 119.10 | |
| Epizyme | 0.6 | $17M | 961k | 17.75 | |
| Syros Pharmaceuticals | 0.6 | $17M | 1.3M | 12.98 | |
| Menlo Therapeutics | 0.6 | $16M | 427k | 37.58 | |
| Cymabay Therapeutics | 0.6 | $16M | 1.2M | 12.99 | |
| eHealth (EHTH) | 0.5 | $15M | 1.0M | 14.31 | |
| Insulet Corporation (PODD) | 0.5 | $15M | 171k | 86.68 | |
| G1 Therapeutics (GTHX) | 0.5 | $14M | 373k | 37.05 | |
| Molina Healthcare (MOH) | 0.5 | $14M | 168k | 81.18 | |
| Immunomedics | 0.5 | $14M | 930k | 14.61 | |
| Zimmer Holdings (ZBH) | 0.5 | $13M | 121k | 109.04 | |
| Ardelyx (ARDX) | 0.5 | $13M | 2.6M | 5.05 | |
| Galapagos Nv- (GLPG) | 0.5 | $13M | 130k | 99.76 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.5 | $13M | 17M | 0.79 | |
| Wright Medical Group Nv | 0.4 | $13M | 634k | 19.84 | |
| Synlogic | 0.4 | $13M | 1.4M | 9.38 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $12M | 582k | 19.90 | |
| Recro Pharma (SCTL) | 0.4 | $11M | 1.0M | 11.01 | |
| Exact Sciences Corp convertible/ | 0.4 | $11M | 13M | 0.89 | |
| Nuvasive Inc note 2.250% 3/1 | 0.4 | $11M | 10M | 1.10 | |
| Teligent Inc note 3.750 12/1 | 0.4 | $11M | 12M | 0.93 | |
| Wave Life Sciences (WVE) | 0.4 | $11M | 268k | 40.10 | |
| Pfenex | 0.3 | $10M | 1.7M | 6.00 | |
| Allscripts Healthcare So conv | 0.3 | $9.7M | 9.7M | 1.00 | |
| Invitae (NVTAQ) | 0.3 | $8.9M | 1.9M | 4.69 | |
| Invuity | 0.3 | $9.0M | 2.3M | 3.85 | |
| Reata Pharmaceuticals Inc Cl A | 0.3 | $8.0M | 390k | 20.51 | |
| BioScrip | 0.3 | $7.7M | 3.1M | 2.46 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $7.7M | 256k | 29.85 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $7.5M | 400k | 18.75 | |
| Neos Therapeutics | 0.2 | $7.2M | 865k | 8.30 | |
| Alpine Immune Sciences (ALPN) | 0.2 | $7.3M | 913k | 8.00 | |
| Bluebird Bio (BLUE) | 0.2 | $7.0M | 41k | 170.76 | |
| Armo Biosciences Ord | 0.2 | $7.1M | 189k | 37.41 | |
| Alimera Sciences | 0.2 | $6.2M | 6.1M | 1.03 | |
| Mirati Therapeutics | 0.2 | $6.0M | 197k | 30.70 | |
| Steadymed | 0.2 | $4.6M | 1.4M | 3.25 | |
| Albireo Pharma | 0.1 | $3.9M | 120k | 32.57 | |
| Sierra Oncology | 0.1 | $3.7M | 1.8M | 2.07 | |
| Foamix Pharmaceuticals | 0.1 | $3.5M | 674k | 5.13 | |
| Mannkind (MNKD) | 0.1 | $3.4M | 1.5M | 2.28 | |
| Proteon Therapeutics | 0.1 | $3.1M | 1.2M | 2.50 | |
| Tactile Systems Technology, In (TCMD) | 0.1 | $2.9M | 91k | 31.80 | |
| Eyenovia Inc equity (EYEN) | 0.1 | $2.7M | 300k | 9.15 | |
| Aralez Pharmaceuticals | 0.1 | $2.5M | 1.6M | 1.50 | |
| Inflarx Nv (IFRX) | 0.1 | $2.6M | 89k | 28.84 | |
| Tesaro | 0.1 | $2.5M | 43k | 57.14 | |
| Voyager Therapeutics (VYGR) | 0.1 | $2.2M | 118k | 18.79 | |
| Adverum Biotechnologies | 0.1 | $2.4M | 422k | 5.80 | |
| Egalet | 0.1 | $2.0M | 3.2M | 0.63 | |
| Ra Pharmaceuticals | 0.1 | $2.0M | 383k | 5.31 | |
| Teligent | 0.1 | $1.6M | 479k | 3.36 | |
| Scynexis | 0.1 | $1.4M | 1.0M | 1.34 | |
| Obalon Therapeutics | 0.1 | $1.5M | 446k | 3.43 | |
| Tandem Diabetes Care (TNDM) | 0.1 | $1.6M | 318k | 4.96 | |
| Sientra | 0.0 | $1.1M | 110k | 9.66 | |
| Orthopediatrics Corp. (KIDS) | 0.0 | $877k | 58k | 15.06 |
